Good morning. My name is Laurel, and I will be your conference operator today. At this time, I would like to welcome everyone to The Hartford Second Quarter 2014 Financial Results Conference Call. [Operator Instructions] I'll now turn the call over to Sabra Purtill, head of Investor Relations. Please, go ahead.

Thank you. Good morning, and welcome to The Hartford Second Quarter 2014 Financial Results Conference Call. We released these results and also filed the investor financial supplement 10-Q and financial results presentation, which includes our third quarter 2014 outlook, yesterday afternoon. All of these documents are available on the Investor Relations section of our website. Our speakers for today's call include Liam McGee, Chairman of The Hartford; Chris Swift, CFO; Doug Elliott, President; and Beth Bombara, CFO. Following their prepared remarks, we will have about 30 minutes for Q&A. I would note that other members of our executive leadership team are also available for questions during that section of the call. As described on Page 2 of the financial results presentation, today's call includes forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. These statements are not guarantees of future performance, and actual results could be materially different. We do not assume any obligation to update forward-looking statements, and investors should consider the risks and uncertainties that cause actual results to differ from these statements. A detailed description of those risks and uncertainties can be found in our SEC filings, which are also available on our website. Our presentation today includes several non-GAAP financial measures. Explanations and reconciliations of these measures to the comparable GAAP measure are included in our SEC filings, as well as in the earnings release and financial supplement. I'll now turn the call over to Liam.

Thank you, Sabra. Good morning, everyone. It's really good to be with you. You know in my life, I don't have much experience working less than full time. So the last few weeks have been welcome as I've been able to focus on my health. And I do appreciate the many expressions that I received from so many of you. And I'm very pleased to report that I'm feeling much better and stronger. I have also had time to reflect on The Hartford's remarkable turnaround and transformation. The Hartford faced severe challenges when I arrived in 2009, and its future was unclear. Today, with a focus on growing profitable businesses, the company's prospects are bright. Now as you know, while we made many changes over the last 5 years, I believe 3 were critical to our success. And we'll continue to deliver shareholder value. We brought clarity to the company's strategic direction, focusing on businesses where we could compete and win. We have invested and we'll continue to invest in new capabilities for those businesses. The result has been sustained margin expansion, with more expected. We significantly lowered the risk profile of the company to a more reasonable level, most importantly recently, with the sale of Japan. This will reduce the volatility of The Hartford's results and will lower our cost of capital going forward. Finally, we focused on generating and freeing up capital. We retained businesses that could create capital and sold other businesses that were capital-consumptive. We also reduced the size and risk of the Talcott Resolution liability, freeing more capital in the process. As a result, The Hartford now has a very strong balance sheet, with the capital flexibility to take accretive actions to create shareholder value. These 3 steps: reducing risk, narrowing the strategic focus and…

Thank you, Liam, for your comments. On behalf of the board, the management team and 18,000 Hartford teammates, I want to thank you for all that you've done for our company. Your willingness to make tough decisions, along with your guidance, leadership and passion, drove the successful transformation of The Hartford. You have positioned the company for great success and the leadership team and I are committed to achieving our vision of an exceptional Hartford. Personally, I am deeply appreciative of our partnership over the last 5 years. Thank you, Liam. I'm honored to serve as CEO of this great company, and I am excited about the path we are on. We continue to execute the company strategy, profitably growing the P&C, Group Benefits, the Mutual Fund businesses, reducing the size and risk of the legacy annuity blocks, and transforming The Hartford into a more effective and efficient organization. We have made tremendous progress. Profit margins are expanding in P&C, Group Benefits and Mutual Funds. All the businesses are growing the top line, with the exception of Group Benefits, where margins have recovered strongly and the top line has stabilized. Although prior year A&E development and elevated storm activity impacted The Hartford's second quarter results, the underlying trends in this quarter reflect a positive momentum in the businesses. In the P&C lines, written premiums grew 3%, and the ex-CAT ex-prior year combined ratio improved 0.9 points from the second quarter of 2013. Written premiums in Small Commercial were up 6%, and the underlying combined ratio was 85.4%, an improvement of 2.2 points compared to the second quarter of 2013. Core earnings in Group Benefits and Mutual Funds increased over the prior year quarters. I am confident we will continue to expand margins. Our pricing levels are higher than our loss…

Thank you, Chris, and good morning, everyone. Before I review the financial results for Commercial and Consumer markets, a few comments on our new team. I'm excited about working more closely with our Consumer Markets group. We have an excellent team and a terrific brand in the consumer space and I'm looking forward to being their partner. I'm also excited about Bill Bloom joining our team. Bill and I have worked together in the past. The leadership and expertise he brings to our organization will be invaluable for our journey ahead, and an excellent fit with the strong technology and operations team that we already have in place. Likewise, I'm very pleased about Ray Sprague's broadened responsibilities across the enterprise. He's a proven leader with deep insurance experience that we will leverage to further expand our franchise. And lastly, we are very fortunate to have Stephanie Bush ready to step into the role as head of Small Commercial. Stephanie has a long and successful track record in P&C Commercial here at The Hartford, and has ideally prepared to take this business to new levels of growth and performance. Now let me get into our results. I'll cover P&C Commercial first, move on to consumer, and conclude with Group Benefit. We had a very solid second quarter in P&C Commercial. Across our business units, we posted quality earnings and delivered strong top line results, even as the market shows signs of growing competitive pressure. Overall, I remained pleased with our execution and confident in our ability to navigate changing market conditions. For the quarter, we delivered core earnings of $213 million on an all-in combined ratio of 94.2. Compared to the second quarter of 2013, this is an increase of $15 million in core earnings, and an improvement of 4.2 points…

Thank you, Doug. Last evening, we reported second quarter core earnings of $144 million or $0.31 per diluted share. Second quarter results included $178 million after tax or $0.38 per diluted share of unfavorable items. The largest item was $164 million after tax of A&E unfavorable prior year development, consisting of $146 million for the annual asbestos reserve study and $18 million for environmental. Aside from these 2 annual studies, unfavorable prior year development was not material, totaling $10 million before tax, of which $7 million was for accretion of discount on worker's compensation reserves. During the quarter, current year catastrophes totaled $127 million after tax, slightly above our outlook. There were 13 named catastrophes with winds and hail being the highest cost perils this quarter. The net loss for the quarter was $467 million or $1 per diluted share compared with the net loss of $190 million or $0.39 per diluted share in the second quarter of 2013. The largest contributor to the net loss for the quarter was the loss in discontinued operations due to the Japan annuity sale, which totaled $617 million after tax. P&C, Group Benefits and Mutual Funds generated core earnings of $113 million, down from $197 million in second quarter 2013, primarily due to the A&E prior year development. As you know, we complete the annual asbestos and environmental studies in the second quarter. Environmental reserve development totaled $27 million before tax in part due to increased cleanup cost on a few water waste sites. The $212 million before tax increase in the asbestos reserve primarily arises from a small number of insured. For those insured, a higher-than-expected frequency and severity of mesothelioma claims drove the reserve increase. We continue to proactively pursue legislative and legal remedies to manage these claim cost, including transparency…

Thank you, Beth. Laurel, could you please repeat the Q&A instructions? [Operator Instructions]

[Operator Instructions] Your first question comes from the line of Jay Cohen with Bank of America.

A couple of questions, maybe first, a big picture question for Chris. As you look out a couple of years, Chris, is there some ROE range that you think the company can achieve if you're looking out to '16 or '17?

Jay, I think Beth tried to describe what we see in the near term through '15 with our announced capital management plans and where we see the momentum of the go-forward business is. When you get in the '16, '17, we previously -- continue to believe we can expand ROE in those years as we continue to grow and manage capital accretively, but probably not at the rate of pace that we see through -- now through the end of '15. So we still believe we're in that 30 to 40, 50-basis-point continual improvement through those years at this point in time. But as you know, when you get further out, Jay, a lot of dynamics in the economics of the P&C cycle and the businesses, but we're still confident that we're going to be able to expand beyond where we see 2015 currently.

Got it. That's helpful, Chris. And second question, maybe for Doug. In the Consumer Markets business, you highlight a certain elevated level of non-CAT weather and fire losses. I'm wondering if you can discuss those losses relative to a normal quarter? How much above typical were those losses?

Jay, it's Doug. Couple of thoughts, you have our detail inside the supplementals. You know that our core accident year, essentially quarter-over-quarter was up 2 points. And that was due to non-CAT, both weather and fire. I would also describe that 2-point change as roughly above normal as well. So I think I would use a couple of points as the answer on both accounts.

I guess I was talking just about the Consumer business. Did I say Commercial? I meant Consumer, if I...

Did I say Commercial? I was talking Consumer.

Your next question comes from the line of Vincent DeAugustino with KBW. Vincent M. DeAugustino - Keefe, Bruyette, & Woods, Inc., Research Division: To start, asbestos is something that we generally can sometimes look through, and so I don't want to get too hung up on it. But we've seen a number of asbestos retro deals, particularly with births [ph] around industry. And I'm just curious if this is something that you'd consider doing and then along with that, how dilutive something like that might actually be relative to the downside on policy limits, sort of as a worst case scenario?

Vincent, I think we're very aware of the third-party solutions that are out there and available in the marketplace. And with that said, where we are today is we haven't found anything that we think is economical for us at this point, and believe really managing these liabilities off ourselves is the optimum strategy. I think also you need to consider that these are really complex claim matters and again, we feel best suited with the expertise that we've built longer -- in a long period of time with John Kinney and his outstanding claims team. And it's really in our best interest to manage our own claims also during this period of time. So you put the economics, you put our claim handling and expertise available, and that's where our current thinking is. Vincent M. DeAugustino - Keefe, Bruyette, & Woods, Inc., Research Division: Okay, good. And then just for a quick follow-up. On the product development side, and with a lot of the defensive work here being a complete to many of Liam's earlier points. I get the sense that there's been an incremental step-up, sort of if we can call it your offense strategy here in 2014. I was hoping to maybe get a preview of any of the new products or distribution opportunities that you might have here on the radar with the new leadership structure.

Vincent, I'll just give you a perspective and I know Doug will want to share his view. So I think you're specifically referring to Ray Sprague joining my leadership team as the head of Strategy and Business Development. And he's got a broad mandate, and the broad mandate is obviously to accelerate our growth and our capabilities and Doug and I, when we talk, and we talk in terms of product, we talk in terms of distribution, we talk in terms of geographic presence. So Ray's got a great track record in being very innovative, creative in the Small Commercial area. So Doug and I want to leverage that capabilities across a broader platform. Doug, what color would you...

Maybe a few more ideas Vincent on top of Chris that I will share with you. In the second quarter, we did announce a new partnership with AARP in the Small Commercial space, so that will be a growing opportunity we look after and work at. Secondly, as we've commented previously, we have a number of initiatives in our Group Benefits space. We rolled out a critical illness product in the second quarter and still working on other products as we move through '14 and to '15. And lastly, and I know we've shared quite a bit of this with you, our journey to round out our Middle Market workers comp book continues. We feel very good about progress in the property and general liability area. But as noted now, new upside structure relative to reinsurance capacity and property, I think allows us to continue to expand. So a lot of work in the product development area across all these businesses.

Your next question comes from the line of Erik Bass with Citigroup.

It's a question for Doug. In commercial lines, as you highlighted, you continue to get rate above your loss cost trends. Just based on what you're seeing in both the industry pricing trend, as well as Hartford's specific dynamics, how much longer do you think that this can continue? Maybe what are you doing that's enabling you to outperform the industry?

Erik, maybe few thoughts for you. First thing I would say is, as we look out 90-plus days. We don't see something dramatic occurring that will have a dramatic shift or impact on the trend line. So I could be wrong, but as I think out and I look at what we're trying to accomplish third quarter beyond, our behavior's going to be very consistent. That's our attempt. Secondly, I'll remind you and others that as we think about margin improvement, and we're constantly thinking about that, there are other levers that we're constantly working. So we're working underwriting, nonrenewal renewal strategies, we have a number of initiatives in our claims area. And so we're working on a number of areas, not just pricing against loss trend, and we feel good about what we've accomplished to date. I know that I've referenced our work in the auto area, it's not a line where we're pleased with the overall performance today. It is getting additional attention. I talked to you about our rate gains in the second quarter. Those gains will continue. That's our intent into quarters 3 and 4 and beyond. So a lot of work going on, and I'm bullish that what we've accomplished so far will be the beginning of a really good path forward.

If I can ask quickly on Group Benefits, where do you think the margins can get to over time? And is it achievable to get back to kind of the 7% range where you were in 2007, 2008?

Erik, it's Chris. In my prepared remarks, we talked in terms of 5.5 on a sustainable basis. So I would temper your expectations a little bit on 7%.

Got it. And what does that translate into an ROE?

I would say again, with the statutory capital and the GAAP capital that we hold against that businesses, we think we could operate in the low double-digits and try to grow it from there.

Your next question comes from the line of Jay Gelb with Barclays.

Chris, with regard to the -- or Beth, with regard to the ROE outlook, I'm thinking that since the life business has the greater portion of the common equity of The Hartford ex AOCI than P&C, but P&C delivers the lion's share of the earnings that it might make sense to explore every avenue to continue to shrink that, the runoff life business, including the U.S. variable annuity. I know you mentioned, you prefer to keep that in-house, but perhaps you could expand your thoughts on that.

Jay, it's Chris. Let me just take the strategy point and then Beth will talk about the ROE implications and the allocation of capital. I think if you think about it, where we're at right now, now that we've sold Japan, we're really left just with a U.S. platform. You've always heard us talk about that we think that risk is -- we understand it very well. It's been managed historically very well. We know how to hedge it. We make about $300 million a year on that VA line of business. Our hedge costs are low, obviously, at these new market levels, including our macro program. So that we really are positioning Talcott as a steady capital provider to the holding company in years to come. And then we'd like to use that capital again to redeploy into higher accretive purposes. So that's sort of a simple model. But I always did say we're always aware of, I'll call it, options out there as a potential tool. But what we see right now for the next -- a couple of years at least, is what we'd like. So Beth, would you share your comment?

Thank you, Chris. And I'll echo a lot of Chris's comments on that, as we sit here day and look at not only just the GAAP earnings generation that comes from the Talcott businesses, but with the elimination of Japan and the reduced volatility from our statutory results, we really do see ourselves on a path of being able to rely more consistently on taking dividends out of the life entities. And all of that obviously, over time, will play into the ROE equation. And it is a balancing act between increasing that ROE, maybe initially and long term, what we think the economics are of this business and provides us with greater, I think, capital flexibility for the long term. But at Chris said, we're always mindful that there are other opportunities to accelerate that, but that's kind of the equation that we go back and forth in our minds with.

That's helpful. And then for the low-9% return equity outlook for 2015, does that assume continued underlying margin expansion in the Property & Casualty business?

Yes, that includes our thoughts going into '15 of the margin expansion that we see in our businesses, as well as the full execution of the current capital management plan that we have.

Your next question comes from the line of Randy Binner with FBR. Randy Binner - FBR Capital Markets & Co., Research Division: I want to go back to asbestos, I'm afraid. I know that there's been issues across the industry, but it's still -- it's a lot of money to lose there opposed to -- for what's supposed to be a decaying liability. And I guess, I want to get a better sense you can provide us with what's going on? I get that it's peripheral defendants by mostly mesothelioma claims, but are you losing at trial? Are you settling more? Are you just spending more on claims and defense costs? I'd like to kind of understand better what's going on. And with a hope to kind of get a sense, objectively, at least, of when we think this might trail off.

Randy, it's Chris. Beth's prepared to give you more insights. But just from my chair and observing this over a little bit of time, you're not going to like this, but there's really nothing new here. I mean, this is still a handful of our accounts. There's nothing new that's sort of bubbling up. When you have, I'll call it, sort of elevated frequency in our accounts and you extend that out over a longer period of time when our model predicts, you can have a relatively large movement in our loss reserves. But Beth will give you a little bit more of the details on what's going on. But the key point here is there's nothing new that we're managing or that we're getting exposed to. It's more of the same.

Yes, Chris, I would agree with that. And again as we said, if you think about the charge that we took, the $212 million pretax, think about roughly 2/3 of that coming from the experience that we're seeing with a small number and you said all the right words, peripheral insureds, where we're seeing an increase in meso claims. And we would have expected to see a decrease. And given the severity that comes with meso claims, and we extrapolate that out through our models, we get the increase that you saw -- that we recorded this quarter. The medical science continues to point to the fact that we should start to see a decrease in these claims. And depending on what activity affects our insureds and the type of coverage that we provided to those specific insureds that see these increases, this is the result that we see. But as Chris said, it's not really anything new. It's just how that activity is affecting our insureds and how it runs through our models where we extrapolate over many, many years. Randy Binner - FBR Capital Markets & Co., Research Division: No, that's helpful. So I mean these are legitimate meso claims. These is not the -- the expansion of liability is more to the peripheral of the defendants but the actual claim is legit, and so you're just having to post more to settle more, basically.

Yes, exactly. This is not like what we saw years and years ago, whereas people who were claiming that they were affected but they had no manifestation of an actual disease.

Your next question comes from the line of John Nadel with Sterne Agee. John M. Nadel - Sterne Agee & Leach Inc., Research Division: A couple of quick questions on the quarter. Doug, you mentioned, I believe in your prepared remarks an expectation for the Consumer Markets expense ratio for the remainder of this year. I was wondering if you could give us any help on your expectations on the Commercial side for the expense ratio as well.

John, let me frame that. There aren't any variations that I think affect your model. And Chris, I can't think of anything relative to run rate that are either front loaded, back loaded, or has some seasonality to it. So John, I think what you've seen is a good indication of where we are, and I think you can move forward from there. John M. Nadel - Sterne Agee & Leach Inc., Research Division: Okay, very helpful. Then on the new Enhanced Surrender program, can you just give us a little bit of color on what you're expecting there? How much account value or number of contracts you're targeting? Should we think about the cost benefit analysis there as being pretty similar to the most recent surrender program on the VA side?

Yes, sure, this is Beth, I'll take that. So again, there's 2 programs. There is, we refer to as the ISV, which is focused on a fixed annuity block, and it's about 4 billion to 5 billion of account value that we are making this offer to. And our expectations on that is that we would see about a 15% take rate. On the ESV program, it's similar to the program that we did last year with some modifications. And again, it is targeted at our variable annuity book and a specific tranche of about $6 billion of account value. And we're assuming there that we'll probably see about a 15% take rate as well. That's down from what we saw with our first program. But we think given the fact that this program -- the offers are a little bit less than before, and we've also been out to this group of policyholders with our first offer so we expect the rate to be a little bit less. And when we put the combination of both programs together and at those take rates, we'd expect to see about $150 million-ish of capital benefit when we look at sort of our stress scenario capital. John M. Nadel - Sterne Agee & Leach Inc., Research Division: And that $150 million is both of them put together?

Both of them put together, yes. John M. Nadel - Sterne Agee & Leach Inc., Research Division: Got it, okay. And then just one final quick question. So I think you ended the quarter with about $1.3 billion of cash and short-term securities at the parent. Can you just sort of roll us forward, because here in a few days, or maybe in the month of July, a lot of things happened, right? You brought in the cash proceeds from the Japan annuity sale, you've done a decent amount of buybacks, including the ASR. So on a pro forma basis at the end of July, would it be correct to just sort of take those couple of things into account and roll it forward, or is there anything else more significant?

That would be the most significant item. The only other item that we did, and it's really a timing item more than anything else, is we did accelerate some of the dividends that we'd normally take out of the P&C legal entities. So if you read our Q, you'll see that in there. And that was about $500 million or so. And that really was just an acceleration of what we normally would have done over the third, fourth and first quarter on the remaining of this year and into next year. It's not an indication that overall, we plan to be taking more of the P&C company going forward.

Your next question comes from the line of Tom Gallagher with Crédit Suisse. Thomas G. Gallagher - Crédit Suisse AG, Research Division: Just wanted to focus on what you've announced for the capital, planned the update in the capital plan. Now that Japan is behind you, should we expect that there's going to be another phase of capital return for 2015 related to risk buffer and U.S. Talcott? And if so, when do you think we'd get an update on that? Or finally, is that more -- it's something that we should be thinking about more for 2016 and not 2015?

It's Chris. Beth will provide some commentary too. So I think you might know this, right? We just announced what we want to do for the rest of '15. So we're going to start getting after that. I think the accelerated plan demonstrates our commitment to really deploy our excess capital in what we think is the most accretive ways. And we'll look -- we're always going to continue to look at the balance sheet, all the combinations of factors in our operating companies, our holding companies, and always challenge ourselves to being as efficient as possible with our capital. So Beth, would you provide any additional color?

Yes, and I think Chris, that summarizes it very well. Again, when you look at the plan that we have announced, a significant amount of both equity repurchases and debt repayments that we'll be dealing for the remainder of '14 and going into '15. And I think we've demonstrated that as we look at our overall capital position and look to manage our Talcott entities at appropriate levels, that to the extent that we were to make any changes of that in the future, we obviously would share that with you. But I would not be expecting some sort of big change coming in the short term as it relates to our capital management plan. But I think more importantly, if I just could add, what we really are focused on is looking at what the statutory capital generation is in the Talcott entities and getting ourselves in a place where we can rely on a predictable stream of cash flows coming out of those entities over time. Thomas G. Gallagher - Crédit Suisse AG, Research Division: And just -- Beth, just a follow-up on that. Does the plan that you just announced contemplate utilizing U.S. Talcott dividends?

So our current plan does anticipate, kind of consistent with where we've talked about before, $250 million, $300 million of dividend, so that is contemplated in the current plan and to some extent, a portion of that was contemplated in the previous plans. Thomas G. Gallagher - Crédit Suisse AG, Research Division: You said $250 million to $300 million?

Yes. Thomas G. Gallagher - Crédit Suisse AG, Research Division: Okay. And just the last question. The $500 million additional debt reduction, can you just bring us up to speed in terms of how far out does that get you? And how should we be thinking about what maturities that takes care of? I believe that actually gets you through more than 2016 maturities, if I'm doing the math correctly, and it would get you out until 2017. Or am I not thinking about that correctly? Is there -- are you more thinking about doing early retirement of some of these maturities?

Yes, so a couple of things. So first of all, with the plan that we had announced earlier this year, as you may recall, we had indicated that we were targeting 2 of the maturities that we have in 2015, which is about $456 million. And so those will come to the normal course. The $500 million that we've allocated for debt repayment for the remainder of this year, we don't have another maturity that would happen in the third or fourth quarter of '14. So we will be looking at either calling a tranche of debt or a tender. But that would be an acceleration. We don't have a maturity that lines up with that.

Laurel, we have time for one more question please?

Your next question comes from the line of Brian Meredith with UBS.

Two quick questions here. First one, Doug, you mentioned elevated property losses in the Middle Market commercial lines space. What would that add to the underlying combined ratio in the quarter, kind of relative with what's normalized?

So we share the underlying and the Middle Market overall combined ratio side. I'd point you there in our supplement. I would characterize the losses as primarily fire, a couple of larger losses in our property book and we also have one in our inland marine book. So somewhat outsized but not -- we don't take enormous retentions. Our retentions are normally under $10 million and so they did cause a little bit of blip in our Middle category.

Can you quantify what the kind of -- was it 1 point, 2 points in the underlying?

There's so much seasonality. I will give you a sense. Our core, as I think about second quarter, non-weather losses over the last 3 or 4 years were higher than the norm by a couple of points overall. So it's not -- certainly not 10 points in the book, right? It's 2 to 3 points. They're having quarters that have had that kind of activity. But relative to 2013, we're a little outsized.

Next question for you Doug. Just curious, now that you're going be running the Consumer business, any changes that you anticipate making and specifically focused on your other agency business that continues to kind of contract here?

So this is 2 days in. No changes planned. We have a terrific franchise with AARP and obviously, you know that I've been deep in the agency space on the Commercial side for the last 25 years. So excited about what we will be doing there, what we're doing there currently today. Just a lot of work in front of me and looking forward with Ray to working with his team. So more to come as we talk forward.

Thank you, Brian. We'd like to thank all of you for joining us today and for your interest in The Hartford. If anyone has any follow-up questions, please feel free to contact either Sean or myself by phone or e-mail. Thank you, and have a good afternoon.

This concludes today's conference call. You may now disconnect.